$15.85
0.140.89%
At Close: -
$15.85
00.00%
After Hours: 5:02 PM EDT
15 minutes delayed
Comments
Loading...
Centessa Pharmaceuticals (NASDAQ:CNTA) Stock, Insider Trading Activity
Centessa Pharmaceuticals: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Centessa Pharmaceuticals PLC Insiders Doing?
At Centessa Pharmaceuticals PLC, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 85.00K shares worth $1.04M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On August 22, 2024, SAURABH SAHA, the company's CHIEF EXECUTIVE OFFICER sold 8.35K shares for $12.28 each.
- On August 23, 2024, Gregory M Weinhoff, the company's CHIEF BUSINESS OFFICER sold 30K shares for $12.24 each.
- On August 23, 2024, SAURABH SAHA, the company's CHIEF EXECUTIVE OFFICER sold 46.65K shares for $12.3 each.
Ownership Statistics for Centessa Pharmaceuticals PLC
Shares Outstanding
113.314M
Insider Shares Owned
3.978M
Insider Percentage Owned
3.51%
Institutional Shares Held
11.181M
Institutional Percentage Held
9.87%
Data brought to you by Benzinga APIs
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
Quote.InsiderTrades.insider-trading-news
No news found